Erin Kavanagh

About Erin Kavanagh

I’m a strategic leader with 9+ years of biopharmaceutical consulting experience translating complex scientific, clinical, and market data into clear, forward-looking strategies that shape global brand planning, pipeline investment, and portfolio decision-making. With deep therapeutic experience in oncology, neurology, and rare diseases, I’ve partnered with cross-functional teams across global organizations to guide brand strategy and insight generation from early development through launch.Skilled in aligning R&D, Medical Affairs, and Commercial functions, I specialize in embedding medical thinking into core brand strategy to drive evidence-based decision-making, support brand differentiation, and accelerate adoption. My work has directly informed global brand planning efforts, supported medical and commercial launch readiness, and enabled teams to anticipate competitive and scientific shifts in dynamic landscapes.Now, I’m looking to transition in-house into the pharmaceutical industry, where I can apply my global experience across launch planning, product strategy, integrated evidence planning, and insight synthesis to help shape and scale transformative therapies for patients worldwide.At the intersection of medical and commercial, I specialize in:• Integrated brand and medical strategy• Competitive intelligence and strategic insight acquisition and analysis• Scientific narrative development • Evidence generation planning• Cross-functional portfolio strategy development and execution• Launch readiness planning• Thought leader engagement• Business developmentAcross more than 15 product launches and multiple global portfolios in oncology, neurology, rare disease, and infectious disease, I’ve helped organizations bring clarity to complexity - positioning assets, guiding go-to-market strategies, and aligning evidence generation with access imperatives. I hope to bring this expertise in-house to contribute to a mission-driven team focused on delivering meaningful impact for patients.

Experience

1. Vice President

   Lumanity

   Apr 2026 — Present

   Lead and collaborate with biopharmaceutical organizations on medical affairs strategy and execution, connecting scientific insights to decisions that drive meaningful impact for patients.

Education

• University of Massachusetts, Amherst

  Master of Science (M.S.)

• University of Massachusetts, Amherst

  Bachelor of Science (B.S.)